{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:28Z","timestamp":1792788328007,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum des Saarlandes und Medizinische Fakult\u00e4t der Universit\u00e4t des Saarlandes","id":[{"id":"https:\/\/ror.org\/01jdpyv68","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Circulating trimethylamine N-oxide (TMAO) may be a causal factor or marker for major adverse cardiac and cerebrovascular events (MACE), but evidence in humans is limited to observational studies with inherent uncertainties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted an umbrella systematic review and meta-analysis of human studies. The search in MEDLINE, Web of Science, Cochrane Library and PROSPERO (last updated in February 2025) identified 120 publications that met our inclusion criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The pooled hazard ratio (HR) and 95% confidence intervals (95%CIs) from 34 cohort studies on TMAO and MACE\u2009=\u20091.20 (1.12\u20131.27), the prediction interval (PI) was 0.93\u20131.54, and I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200973.3%. After correction for publication bias (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 Egger\u2019s test), the pooled HR (95%CIs) was 1.10 (1.03\u20131.17). The pooled odds ratio (95%CIs) from 18 case-control studies after accounting for publication bias was 1.05 (0.94\u20131.18). As a diagnostic test, the estimated pooled area under the curve (95%CIs) for TMAO was 72.8 (68.8\u201377.1)%, PI\u2009=\u200954.7%\u201397.1%, I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200993.8%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924 studies. The mean (95%CIs) sensitivity and specificity of TMAO were 65.3 (56.1\u201374.5)% and 79.0 (65.4\u201392.6)%, respectively. The data did not suggest a threshold for elevated TMAO concentrations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Previously reported association estimates between TMAO and MACE in human studies are systematically overestimated. The results do not support TMAO being a causal factor or marker of MACE and related conditions. Harmonisation of TMAO measurements between labs and cohort studies in healthy people that address confounding factors remain critically needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12986-026-01214-0","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:03:11Z","timestamp":1790150591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trimethylamine N-oxide and major adverse cardiac and cerebrovascular events: results of umbrella review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Rima","family":"Obeid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insa","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Geisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Colin","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"1214_CR1","doi-asserted-by":"publisher","first-page":"1287928","DOI":"10.3389\/fneur.2023.1287928","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, Nan Y, Zhu W, Wang S. Effect of TMAO on the incidence and prognosis of cerebral infarction: a systematic review and meta-analysis. Front Neurol. 2023;14:1287928.","journal-title":"Front Neurol"},{"key":"1214_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11739-020-02470-5","volume":"16","author":"L Guasti","year":"2021","unstructured":"Guasti L, Galliazzo S, Molaro M, Visconti E, Pennella B, Gaudio GV, et al. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis. Intern Emerg Med. 2021;16:201\u20137.","journal-title":"Intern Emerg Med"},{"key":"1214_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WH Tang","year":"2015","unstructured":"Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116:448\u201355.","journal-title":"Circ Res"},{"key":"1214_CR4","doi-asserted-by":"publisher","first-page":"e085749","DOI":"10.1136\/bmj-2025-085749","volume":"392","author":"JA Labrecque","year":"2026","unstructured":"Labrecque JA, Kezios KL. How and when to use causal and associational language. BMJ. 2026;392:e085749.","journal-title":"BMJ"},{"key":"1214_CR5","doi-asserted-by":"publisher","first-page":"103908","DOI":"10.1016\/j.numecd.2025.103908","volume":"35","author":"R Obeid","year":"2025","unstructured":"Obeid R, Mohr L, White BA, Heine GH, Emrich I, Geisel J, et al. Circulating trimethylamine N-oxide and cardiovascular, cerebral, and renal diseases including mortality: Umbrella review of published systematic reviews and meta-analyses. Nutr Metab Cardiovasc Dis. 2025;35:103908.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1214_CR6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/nu15040812","volume":"15","author":"NA Kalagi","year":"2023","unstructured":"Kalagi NA, Thota RN, Stojanovski E, Alburikan KA, Garg ML. Plasma Trimethylamine N-Oxide Levels Are Associated with Poor Kidney Function in People with Type 2 Diabetes. Nutrients. 2023;15:812.","journal-title":"Nutrients"},{"key":"1214_CR7","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1038\/s41467-023-39824-4","volume":"14","author":"P Andrikopoulos","year":"2023","unstructured":"Andrikopoulos P, Aron-Wisnewsky J, Chakaroun R, Myridakis A, Forslund SK, Nielsen T, et al. Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide. Nat Commun. 2023;14:5843.","journal-title":"Nat Commun"},{"key":"1214_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10654-021-00794-w","volume":"36","author":"CL Ramspek","year":"2021","unstructured":"Ramspek CL, Steyerberg EW, Riley RD, Rosendaal FR, Dekkers OM, Dekker FW, et al. Prediction or causality? A scoping review of their conflation within current observational research. Eur J Epidemiol. 2021;36:889\u201398.","journal-title":"Eur J Epidemiol"},{"key":"1214_CR9","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.kint.2016.01.014","volume":"89","author":"RB Kim","year":"2016","unstructured":"Kim RB, Morse BL, Djurdjev O, Tang M, Muirhead N, Barrett B, et al. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events. Kidney Int. 2016;89:1144\u201352.","journal-title":"Kidney Int"},{"key":"1214_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/heartjnl-2015-308826","volume":"102","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, Heaney LM, Bhandari SS, Jones DJ, Ng LL. Trimethylamine N-oxide and prognosis in acute heart failure. Heart. 2016;102:841\u20138.","journal-title":"Heart"},{"key":"1214_CR11","doi-asserted-by":"publisher","first-page":"e0141738","DOI":"10.1371\/journal.pone.0141738","volume":"11","author":"C Missailidis","year":"2016","unstructured":"Missailidis C, Hallqvist J, Qureshi AR, Barany P, Heimburger O, Lindholm B, et al. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease. PLoS ONE. 2016;11:e0141738.","journal-title":"PLoS ONE"},{"key":"1214_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.celrep.2014.12.036","volume":"10","author":"M Warrier","year":"2015","unstructured":"Warrier M, Shih DM, Burrows AC, Ferguson D, Gromovsky AD, Brown AL, et al. The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance. Cell Rep. 2015;10:326\u201338.","journal-title":"Cell Rep"},{"key":"1214_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell. 2016;165:111\u201324.","journal-title":"Cell"},{"key":"1214_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","volume":"21","author":"E Bosco","year":"2021","unstructured":"Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21:241.","journal-title":"BMC Med Res Methodol"},{"key":"1214_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/jrsm.1356","volume":"10","author":"RCM van Aert","year":"2019","unstructured":"van Aert RCM, Jackson D. A new justification of the Hartung-Knapp method for random-effects meta-analysis based on weighted least squares regression. Res Synth Methods. 2019;10:515\u201327.","journal-title":"Res Synth Methods"},{"key":"1214_CR16","doi-asserted-by":"publisher","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","volume":"6","author":"J IntHout","year":"2016","unstructured":"IntHout J, Ioannidis JP, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6:e010247.","journal-title":"BMJ Open"},{"key":"1214_CR17","first-page":"814","volume":"38","author":"XS Li","year":"2017","unstructured":"Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Raber L, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J. 2017;38:814\u201324.","journal-title":"Eur Heart J"},{"key":"1214_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1373\/clinchem.2016.263640","volume":"63","author":"WH Tang","year":"2017","unstructured":"Tang WH, Wang Z, Li XS, Fan Y, Li DS, Wu Y, et al. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus. Clin Chem. 2017;63:297\u2013306.","journal-title":"Clin Chem"},{"key":"1214_CR19","doi-asserted-by":"publisher","first-page":"e004237","DOI":"10.1161\/JAHA.116.004237","volume":"5","author":"V Senthong","year":"2016","unstructured":"Senthong V, Wang Z, Fan Y, Wu Y, Hazen SL, Tang WH. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease. J Am Heart Assoc. 2016;5:e004237.","journal-title":"J Am Heart Assoc"},{"key":"1214_CR20","doi-asserted-by":"publisher","first-page":"e002816","DOI":"10.1161\/JAHA.115.002816","volume":"5","author":"V Senthong","year":"2016","unstructured":"Senthong V, Wang Z, Li XS, Fan Y, Wu Y, Tang WH, et al. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort. J Am Heart Assoc. 2016;5:e002816.","journal-title":"J Am Heart Assoc"},{"key":"1214_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cardfail.2014.11.006","volume":"21","author":"WH Tang","year":"2015","unstructured":"Tang WH, Wang Z, Shrestha K, Borowski AG, Wu Y, Troughton RW, et al. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J Card Fail. 2015;21:91\u20136.","journal-title":"J Card Fail"},{"key":"1214_CR22","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WH Tang","year":"2014","unstructured":"Tang WH, Wang Z, Fan Y, Levison B, Hazen JE, Donahue LM, et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol. 2014;64:1908\u201314.","journal-title":"J Am Coll Cardiol"},{"key":"1214_CR23","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575\u201384.","journal-title":"N Engl J Med"},{"key":"1214_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57\u201363.","journal-title":"Nature"},{"key":"1214_CR25","doi-asserted-by":"publisher","first-page":"e027265","DOI":"10.1161\/JAHA.122.027265","volume":"11","author":"J Xue","year":"2022","unstructured":"Xue J, Xu J, Zhao M, Jin A, Cheng A, Jiang X, et al. Residual risk of trimethylamine-N-oxide and choline for stroke recurrence in patients with intensive secondary therapy. J Am Heart Assoc. 2022;11:e027265.","journal-title":"J Am Heart Assoc"},{"key":"1214_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1159\/000523919","volume":"51","author":"J Xu","year":"2022","unstructured":"Xu J, Mo J, Zhang X, Chen Z, Pan Y, Yan H, et al. Nontraditional Risk Factors for Residual Recurrence Risk in Patients with Ischemic Stroke of Different Etiologies. Cerebrovasc Dis. 2022;51:630\u20138.","journal-title":"Cerebrovasc Dis"},{"key":"1214_CR27","doi-asserted-by":"publisher","first-page":"e020979","DOI":"10.1161\/JAHA.121.020979","volume":"10","author":"J Xu","year":"2021","unstructured":"Xu J, Zhao M, Wang A, Xue J, Cheng S, Cheng A, et al. Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke. J Am Heart Assoc. 2021;10:e020979.","journal-title":"J Am Heart Assoc"},{"key":"1214_CR28","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/STROKEAHA.120.031443","volume":"53","author":"J Xu","year":"2022","unstructured":"Xu J, Cheng A, Song B, Zhao M, Xue J, Wang A, et al. Trimethylamine N-Oxide and Stroke Recurrence Depends on Ischemic Stroke Subtypes. Stroke. 2022;53:1207\u201315. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031443","journal-title":"Stroke"},{"key":"1214_CR29","doi-asserted-by":"publisher","first-page":"e011569","DOI":"10.1161\/CIRCHEARTFAILURE.124.011569","volume":"17","author":"WHW Tang","year":"2024","unstructured":"Tang WHW, Lemaitre RN, Jensen PN, Wang M, Wang Z, Li XS, et al. Trimethylamine N-Oxide and Related Gut Microbe-Derived Metabolites and Incident Heart Failure Development in Community-Based Populations. Circ Heart Fail. 2024;17:e011569.","journal-title":"Circ Heart Fail"},{"key":"1214_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1681\/ASN.0000000000000344","volume":"35","author":"M Wang","year":"2024","unstructured":"Wang M, Tang WHW, Li XS, de Oliveira Otto MC, Lee Y, Lemaitre RN, et al. The Gut Microbial Metabolite Trimethylamine N -oxide, Incident CKD, and Kidney Function Decline. J Am Soc Nephrol. 2024;35:749\u201360.","journal-title":"J Am Soc Nephrol"},{"key":"1214_CR31","doi-asserted-by":"publisher","first-page":"e8711","DOI":"10.1161\/JAHA.122.029230","volume":"12","author":"RN Lemaitre","year":"2023","unstructured":"Lemaitre RN, Jensen PN, Wang Z, Fretts AM, Sitlani CM, Nemet I, et al. Plasma Trimethylamine-N-Oxide and Incident Ischemic Stroke: The Cardiovascular Health Study and the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2023;12:e8711.","journal-title":"J Am Heart Assoc"},{"key":"1214_CR32","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1111\/liv.14963","volume":"41","author":"JL Flores-Guerrero","year":"2021","unstructured":"Flores-Guerrero JL, Post A, van Dijk PR, Connelly MA, Garcia E, Navis G, et al. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease. Liver Int. 2021;41:2371\u201382.","journal-title":"Liver Int"},{"key":"1214_CR33","doi-asserted-by":"publisher","first-page":"13781","DOI":"10.1038\/s41598-017-13739-9","volume":"7","author":"EG Gruppen","year":"2017","unstructured":"Gruppen EG, Garcia E, Connelly MA, Jeyarajah EJ, Otvos JD, Bakker SJL, et al. TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function. Sci Rep. 2017;7:13781.","journal-title":"Sci Rep"},{"key":"1214_CR34","doi-asserted-by":"publisher","first-page":"e006524","DOI":"10.1161\/JAHA.117.006524","volume":"6","author":"M Guasch-Ferre","year":"2017","unstructured":"Guasch-Ferre M, Hu FB, Ruiz-Canela M, Bullo M, Toledo E, Wang DD, et al. Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study. J Am Heart Assoc. 2017;6:e006524.","journal-title":"J Am Heart Assoc"},{"key":"1214_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/clinchem\/hvaa224","volume":"67","author":"C Papandreou","year":"2021","unstructured":"Papandreou C, Bullo M, Hernandez-Alonso P, Ruiz-Canela M, Li J, Guasch-Ferre M, et al. Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study. Clin Chem. 2021;67:288\u201397.","journal-title":"Clin Chem"},{"key":"1214_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ahj.2021.01.006","volume":"234","author":"MZ Israr","year":"2021","unstructured":"Israr MZ, Bernieh D, Salzano A, Cassambai S, Yazaki Y, Heaney LM, et al. Association of gut-related metabolites with outcome in acute heart failure. Am Heart J. 2021;234:71\u201380.","journal-title":"Am Heart J"},{"key":"1214_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1373\/clinchem.2016.264853","volume":"63","author":"T Suzuki","year":"2017","unstructured":"Suzuki T, Heaney LM, Jones DJ, Ng LL. Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction. Clin Chem. 2017;63:420\u20138.","journal-title":"Clin Chem"},{"key":"1214_CR38","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1177\/2047487319870355","volume":"27","author":"A Salzano","year":"2020","unstructured":"Salzano A, Israr MZ, Yazaki Y, Heaney LM, Kanagala P, Singh A, et al. Combined use of trimethylamine N-oxide with BNP for risk stratification in heart failure with preserved ejection fraction: findings from the DIAMONDHFpEF study. Eur J Prev Cardiol. 2020;27:2159\u201362.","journal-title":"Eur J Prev Cardiol"},{"key":"1214_CR39","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/ehf2.12777","volume":"7","author":"Y Yazaki","year":"2020","unstructured":"Yazaki Y, Aizawa K, Israr MZ, Negishi K, Salzano A, Saitoh Y, et al. Ethnic differences in association of outcomes with trimethylamine N-oxide in acute heart failure patients. ESC Heart Fail. 2020;7:2373\u20138.","journal-title":"ESC Heart Fail"},{"key":"1214_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fneur.2020.00029","volume":"11","author":"C Tan","year":"2020","unstructured":"Tan C, Wang H, Gao X, Xu R, Zeng X, Cui Z, et al. Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke. Front Neurol. 2020;11:29.","journal-title":"Front Neurol"},{"key":"1214_CR41","doi-asserted-by":"publisher","first-page":"e1283","DOI":"10.1212\/WNL.0000000000005298","volume":"90","author":"C Wu","year":"2018","unstructured":"Wu C, Li C, Zhao W, Xie N, Yan F, Lian Y, et al. Elevated trimethylamine N-oxide related to ischemic brain lesions after carotid artery stenting. Neurology. 2018;90:e1283\u201390.","journal-title":"Neurology"},{"key":"1214_CR42","doi-asserted-by":"publisher","first-page":"e003970","DOI":"10.1161\/JAHA.116.003970","volume":"5","author":"KA Meyer","year":"2016","unstructured":"Meyer KA, Benton TZ, Bennett BJ, Jacobs DR Jr., Lloyd-Jones DM, Gross MD, et al. Microbiota-Dependent Metabolite Trimethylamine N-Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA). J Am Heart Assoc. 2016;5:e003970.","journal-title":"J Am Heart Assoc"},{"key":"1214_CR43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1053\/j.jrn.2024.03.009","volume":"34","author":"R Obeid","year":"2024","unstructured":"Obeid R, Awwad H, Heine GH, Emrich IE, Fliser D, Zawada AM, et al. Plasma Concentrations of Trimethylamine-N-Oxide, Choline, and Betaine in Patients With Moderate to Advanced Chronic Kidney Disease and Their Relation to Cardiovascular and Renal Outcomes. J Ren Nutr. 2024;34:530\u20138.","journal-title":"J Ren Nutr"},{"key":"1214_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ajcnut.2023.10.012","volume":"119","author":"JW Shea","year":"2024","unstructured":"Shea JW, Jacobs DR Jr., Howard AG, Lulla A, Lloyd-Jones DM, Murthy VL, et al. Choline metabolites and incident cardiovascular disease in a prospective cohort of adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr. 2024;119:29\u201338.","journal-title":"Am J Clin Nutr"},{"key":"1214_CR45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/heartjnl-2022-321300","volume":"109","author":"M Luciani","year":"2023","unstructured":"Luciani M, Muller D, Vanetta C, Diteepeng T, von Aeschbacher EA. Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation. Heart. 2023;109:396\u2013404.","journal-title":"Heart"},{"key":"1214_CR46","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/jcdd9110380","volume":"9","author":"N Li","year":"2022","unstructured":"Li N, Wang Y, Zhou J, Chen R, Li J, Zhao X, et al. Association between the Changes in Trimethylamine N-Oxide-Related Metabolites and Prognosis of Patients with Acute Myocardial Infarction: A Prospective Study. J Cardiovasc Dev Dis. 2022;9:380.","journal-title":"J Cardiovasc Dev Dis"},{"key":"1214_CR47","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1093\/ajcn\/nqac278","volume":"116","author":"L Dai","year":"2022","unstructured":"Dai L, Massy ZA, Stenvinkel P, Chesnaye NC, Larabi IA, Alvarez JC, et al. The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study. Am J Clin Nutr. 2022;116:1842\u201351.","journal-title":"Am J Clin Nutr"},{"key":"1214_CR48","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/joim.13550","volume":"292","author":"EO Bjornestad","year":"2022","unstructured":"Bjornestad EO, Dhar I, Svingen GFT, Pedersen ER, Orn S, Svenningsson MM, et al. Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease. J Intern Med. 2022;292:915\u201324.","journal-title":"J Intern Med"},{"key":"1214_CR49","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1002\/ehf2.14009","volume":"9","author":"N Li","year":"2022","unstructured":"Li N, Zhou J, Wang Y, Chen R, Li J, Zhao X, et al. Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure. ESC Heart Fail. 2022;9:3846\u201357.","journal-title":"ESC Heart Fail"},{"key":"1214_CR50","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1053\/j.ajkd.2022.02.016","volume":"80","author":"H Sapa","year":"2022","unstructured":"Sapa H, Gutierrez OM, Shlipak MG, Katz R, Ix JH, Sarnak MJ, et al. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease. Am J Kidney Dis. 2022;80:502\u201312.","journal-title":"Am J Kidney Dis"},{"key":"1214_CR51","doi-asserted-by":"publisher","first-page":"107602962210905","DOI":"10.1177\/10760296221090503","volume":"28","author":"YY Chen","year":"2022","unstructured":"Chen YY, Ye ZS, Xia NG, Xu Y. TMAO as a Novel Predictor of Major Adverse Vascular Events and Recurrence in Patients with Large Artery Atherosclerotic Ischemic Stroke. Clin Appl Thromb Hemost. 2022;28:10760296221090503.","journal-title":"Clin Appl Thromb Hemost"},{"key":"1214_CR52","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00392-022-01992-6","volume":"111","author":"M Amrein","year":"2022","unstructured":"Amrein M, Li XS, Walter J, Wang Z, Zimmermann T, Strebel I, et al. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD). Clin Res Cardiol. 2022;111:692\u2013704.","journal-title":"Clin Res Cardiol"},{"key":"1214_CR53","doi-asserted-by":"publisher","first-page":"728724","DOI":"10.3389\/fcvm.2021.728724","volume":"8","author":"C Eyileten","year":"2021","unstructured":"Eyileten C, Jarosz-Popek J, Jakubik D, Gasecka A, Wolska M, Ufnal M, et al. Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome. Front Cardiovasc Med. 2021;8:728724.","journal-title":"Front Cardiovasc Med"},{"key":"1214_CR54","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1177\/08968608211051809","volume":"42","author":"D Chang","year":"2022","unstructured":"Chang D, Xu X, Yang Z, Ma T, Nie J, Dong J. Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis. Perit Dial Int. 2022;42:622\u201330.","journal-title":"Perit Dial Int"},{"key":"1214_CR55","doi-asserted-by":"publisher","first-page":"e020646","DOI":"10.1161\/JAHA.120.020646","volume":"10","author":"Y Lee","year":"2021","unstructured":"Lee Y, Nemet I, Wang Z, Lai HTM, de Oliveira Otto MC, Lemaitre RN, et al. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults. J Am Heart Assoc. 2021;10:e020646.","journal-title":"J Am Heart Assoc"},{"key":"1214_CR56","doi-asserted-by":"publisher","first-page":"e0244402","DOI":"10.1371\/journal.pone.0244402","volume":"16","author":"SA Winther","year":"2021","unstructured":"Winther SA, Ollgaard JC, Hansen TW, von Scholten BJ, Reinhard H, Ahluwalia TS, et al. Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria. PLoS ONE. 2021;16:e0244402.","journal-title":"PLoS ONE"},{"key":"1214_CR57","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1159\/000512962","volume":"50","author":"D Fu","year":"2021","unstructured":"Fu D, Shen J, Li W, Wang Y, Zhong Z, Ye H, et al. Elevated Serum Trimethylamine N-Oxide Levels Are Associated with Mortality in Male Patients on Peritoneal Dialysis. Blood Purif. 2021;50:837\u201347.","journal-title":"Blood Purif"},{"key":"1214_CR58","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1080\/0886022X.2020.1822868","volume":"42","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zou JZ, Chen J, Tan X, Xiang FF, Shen B, et al. Association of trimethylamine N-Oxide with cardiovascular and all-cause mortality in hemodialysis patients. Ren Fail. 2020;42:1004\u201314.","journal-title":"Ren Fail"},{"key":"1214_CR59","doi-asserted-by":"publisher","first-page":"dgaa188","DOI":"10.1210\/clinem\/dgaa188","volume":"105","author":"M Croyal","year":"2020","unstructured":"Croyal M, Saulnier PJ, Aguesse A, Gand E, Ragot S, Roussel R, et al. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes. J Clin Endocrinol Metab. 2020;105:dgaa188.","journal-title":"J Clin Endocrinol Metab"},{"key":"1214_CR60","doi-asserted-by":"publisher","first-page":"15580","DOI":"10.1038\/s41598-019-52082-z","volume":"9","author":"C Roncal","year":"2019","unstructured":"Roncal C, Martinez-Aguilar E, Orbe J, Ravassa S, Fernandez-Montero A, Saenz-Pipaon G, et al. Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease. Sci Rep. 2019;9:15580.","journal-title":"Sci Rep"},{"key":"1214_CR61","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2337\/dc19-0048","volume":"42","author":"SA Winther","year":"2019","unstructured":"Winther SA, Ollgaard JC, Tofte N, Tarnow L, Wang Z, Ahluwalia TS, et al. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes. Diabetes Care. 2019;42:1512\u201320.","journal-title":"Diabetes Care"},{"key":"1214_CR62","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2215\/CJN.06190518","volume":"14","author":"JR Stubbs","year":"2019","unstructured":"Stubbs JR, Stedman MR, Liu S, Long J, Franchetti Y, West RE III, et al. Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis. Clin J Am Soc Nephrol. 2019;14:261\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1214_CR63","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1161\/ATVBAHA.118.311023","volume":"38","author":"A Haghikia","year":"2018","unstructured":"Haghikia A, Li XS, Liman TG, Bledau N, Schmidt D, Zimmermann F, et al. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes. Arterioscler Thromb Vasc Biol. 2018;38:2225\u201335.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1214_CR64","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1016\/j.jacc.2017.10.064","volume":"70","author":"K Schuett","year":"2017","unstructured":"Schuett K, Kleber ME, Scharnagl H, Lorkowski S, Marz W, Niessner A, et al. Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction. J Am Coll Cardiol. 2017;70:3202\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"1214_CR65","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1681\/ASN.2016030374","volume":"28","author":"T Shafi","year":"2017","unstructured":"Shafi T, Powe NR, Meyer TW, Hwang S, Hai X, Melamed ML, et al. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. J Am Soc Nephrol. 2017;28:321\u201331.","journal-title":"J Am Soc Nephrol"},{"key":"1214_CR66","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.atherosclerosis.2016.01.033","volume":"247","author":"K Skagen","year":"2016","unstructured":"Skagen K, Troseid M, Ueland T, Holm S, Abbas A, Gregersen I, et al. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis. Atherosclerosis. 2016;247:64\u20139.","journal-title":"Atherosclerosis"},{"key":"1214_CR67","doi-asserted-by":"publisher","first-page":"e114969","DOI":"10.1371\/journal.pone.0114969","volume":"9","author":"M Lever","year":"2014","unstructured":"Lever M, George PM, Slow S, Bellamy D, Young JM, Ho M, et al. Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study. PLoS ONE. 2014;9:e114969.","journal-title":"PLoS ONE"},{"key":"1214_CR68","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.atherosclerosis.2015.10.091","volume":"243","author":"DM Mueller","year":"2015","unstructured":"Mueller DM, Allenspach M, Othman A, Saely CH, Muendlein A, Vonbank A, et al. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. Atherosclerosis. 2015;243:638\u201344.","journal-title":"Atherosclerosis"},{"key":"1214_CR69","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3390\/jcm10112269","volume":"10","author":"JL Flores-Guerrero","year":"2021","unstructured":"Flores-Guerrero JL, van Dijk PR, Connelly MA, Garcia E, Bilo HJG, Navis G, et al. Circulating Trimethylamine N-Oxide Is Associated with Increased Risk of Cardiovascular Mortality in Type-2 Diabetes: Results from a Dutch Diabetes Cohort (ZODIAC-59). J Clin Med. 2021;10:2269.","journal-title":"J Clin Med"},{"key":"1214_CR70","doi-asserted-by":"publisher","first-page":"e002699","DOI":"10.1161\/JAHA.115.002699","volume":"4","author":"J Yin","year":"2015","unstructured":"Yin J, Liao SX, He Y, Wang S, Xia GH, Liu FT, et al. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack. J Am Heart Assoc. 2015;4:e002699.","journal-title":"J Am Heart Assoc"},{"key":"1214_CR71","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/QAI.0000000000000937","volume":"72","author":"PE Miller","year":"2016","unstructured":"Miller PE, Haberlen SA, Brown TT, Margolick JB, DiDonato JA, Hazen SL, et al. Brief Report: Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association With Coronary Stenosis and HIV Serostatus. J Acquir Immune Defic Syndr. 2016;72:114\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1214_CR72","doi-asserted-by":"publisher","first-page":"BSR20232090","DOI":"10.1042\/BSR20232090","volume":"44","author":"N Spasova","year":"2024","unstructured":"Spasova N, Somleva D, Krastev B, Ilieva R, Borizanova A, Svinarov D, et al. Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases. Biosci Rep. 2024;44:BSR20232090.","journal-title":"Biosci Rep"},{"key":"1214_CR73","doi-asserted-by":"publisher","first-page":"15097","DOI":"10.1021\/acs.jafc.2c08241","volume":"71","author":"S Huang","year":"2023","unstructured":"Huang S, Lim SY, Tan SH, Chan MY, Ni W, Li SFY. Targeted Plasma Metabolomics Reveals Association of Acute Myocardial Infarction Risk with the Dynamic Balance between Trimethylamine-N-oxide, Betaine, and Choline. J Agric Food Chem. 2023;71:15097\u2013105.","journal-title":"J Agric Food Chem"},{"key":"1214_CR74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/joim.13572","volume":"293","author":"D Liu","year":"2023","unstructured":"Liu D, Gu S, Zhou Z, Ma Z, Zuo H. Associations of plasma TMAO and its precursors with stroke risk in the general population: A nested case-control study. J Intern Med. 2023;293:110\u201320.","journal-title":"J Intern Med"},{"key":"1214_CR75","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2021.09.026","volume":"335","author":"C Ringel","year":"2021","unstructured":"Ringel C, Dittrich J, Gaudl A, Schellong P, Beuchel CF, Baber R, et al. Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome. Atherosclerosis. 2021;335:62\u20137.","journal-title":"Atherosclerosis"},{"key":"1214_CR76","doi-asserted-by":"publisher","first-page":"5549796","DOI":"10.1155\/2021\/5549796","volume":"2021","author":"D Xu","year":"2021","unstructured":"Xu D, Zhao W, Song J, Yin L, Wang K, Wei L, et al. The Relationship of Large-Artery Atherothrombotic Stroke with Plasma Trimethylamine N-Oxide Level and Blood Lipid-Related Indices: A Cross-Sectional Comparative Study. Biomed Res Int. 2021;2021:5549796.","journal-title":"Biomed Res Int"},{"key":"1214_CR77","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/ajcn\/nqab053","volume":"114","author":"G Liu","year":"2021","unstructured":"Liu G, Li J, Li Y, Hu Y, Franke AA, Liang L, et al. Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women. Am J Clin Nutr. 2021;114:238\u201347.","journal-title":"Am J Clin Nutr"},{"key":"1214_CR78","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ahj.2021.01.020","volume":"236","author":"WHW Tang","year":"2021","unstructured":"Tang WHW, Li XS, Wu Y, Wang Z, Khaw KT, Wareham NJ, et al. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study. Am Heart J. 2021;236:80\u20136.","journal-title":"Am Heart J"},{"key":"1214_CR79","doi-asserted-by":"publisher","first-page":"5854919","DOI":"10.1155\/2020\/5854919","volume":"2020","author":"F Guo","year":"2020","unstructured":"Guo F, Zhou J, Li Z, Yu Z, Ouyang D. The Association between Trimethylamine N-Oxide and Its Predecessors Choline, L-Carnitine, and Betaine with Coronary Artery Disease and Artery Stenosis. Cardiol Res Pract. 2020;2020:5854919.","journal-title":"Cardiol Res Pract"},{"key":"1214_CR80","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5551\/jat.55962","volume":"28","author":"T Sun","year":"2021","unstructured":"Sun T, Zhang Y, Yin J, Peng X, Zhou L, Huang S, et al. Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke. J Atheroscler Thromb. 2021;28:320\u20138.","journal-title":"J Atheroscler Thromb"},{"key":"1214_CR81","doi-asserted-by":"publisher","first-page":"e015331","DOI":"10.1161\/JAHA.119.015331","volume":"9","author":"B Gencer","year":"2020","unstructured":"Gencer B, Li XS, Gurmu Y, Bonaca MP, Morrow DA, Cohen M, et al. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial. J Am Heart Assoc. 2020;9:e015331.","journal-title":"J Am Heart Assoc"},{"key":"1214_CR82","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/ene.14253","volume":"27","author":"C Schneider","year":"2020","unstructured":"Schneider C, Okun JG, Schwarz KV, Hauke J, Zorn M, Nurnberg C, et al. Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days. Eur J Neurol. 2020;27:1596\u2013603.","journal-title":"Eur J Neurol"},{"key":"1214_CR83","doi-asserted-by":"publisher","first-page":"e000718","DOI":"10.1136\/bmjdrc-2019-000718","volume":"7","author":"A Cardona","year":"2019","unstructured":"Cardona A, O\u2019Brien A, Bernier MC, Somogyi A, Wysocki VH, Smart S, et al. Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis. BMJ Open Diabetes Res Care. 2019;7:e000718.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1214_CR84","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.atherosclerosis.2018.11.010","volume":"280","author":"L Zheng","year":"2019","unstructured":"Zheng L, Zheng J, Xie Y, Li Z, Guo X, Sun G, et al. Serum gut microbe-dependent trimethylamine N-oxide improves the prediction of future cardiovascular disease in a community-based general population. Atherosclerosis. 2019;280:126\u201331.","journal-title":"Atherosclerosis"},{"key":"1214_CR85","doi-asserted-by":"publisher","first-page":"e22246","DOI":"10.1002\/jbt.22246","volume":"33","author":"Z Liang","year":"2019","unstructured":"Liang Z, Dong Z, Guo M, Shen Z, Yin D, Hu S, et al. Trimethylamine N-oxide as a risk marker for ischemic stroke in patients with atrial fibrillation. J Biochem Mol Toxicol. 2019;33:e22246.","journal-title":"J Biochem Mol Toxicol"},{"key":"1214_CR86","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/STROKEAHA.118.021997","volume":"49","author":"J Nie","year":"2018","unstructured":"Nie J, Xie L, Zhao BX, Li Y, Qiu B, Zhu F, et al. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients. Stroke. 2018;49:2021\u20138.","journal-title":"Stroke"},{"key":"1214_CR87","doi-asserted-by":"publisher","first-page":"1578320","DOI":"10.1155\/2018\/1578320","volume":"2018","author":"Z Dong","year":"2018","unstructured":"Dong Z, Liang Z, Guo M, Hu S, Shen Z, Hai X. The Association between Plasma Levels of Trimethylamine N-Oxide and the Risk of Coronary Heart Disease in Chinese Patients with or without Type 2 Diabetes Mellitus. Dis Markers. 2018;2018:1578320.","journal-title":"Dis Markers"},{"key":"1214_CR88","first-page":"1189","volume":"31","author":"A Mente","year":"2015","unstructured":"Mente A, Chalcraft K, Ak H, Davis AD, Lonn E, Miller R, et al. The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada. Can J Cardiol. 2015;31:1189\u201394.","journal-title":"Can J Cardiol"},{"key":"1214_CR89","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1210\/clinem\/dgae009","volume":"109","author":"PS Yu","year":"2024","unstructured":"Yu PS, Wu PH, Hung WW, Lin MY, Zhen YY, Hung WC, et al. Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2024;109:2097\u2013105.","journal-title":"J Clin Endocrinol Metab"},{"key":"1214_CR90","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1053\/j.jrn.2022.11.001","volume":"33","author":"X Yuan","year":"2023","unstructured":"Yuan X, Wei X, Liu J, Tang C, Peng L, Wang H, et al. Association of Circulating Trimethylamine-N Oxide With Malnutrition and the Risk of Coronary Artery Disease in Patients With Maintenance Hemodialysis. J Ren Nutr. 2023;33:465\u201371.","journal-title":"J Ren Nutr"},{"key":"1214_CR91","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1080\/0886022X.2022.2145971","volume":"44","author":"L He","year":"2022","unstructured":"He L, Yang W, Yang P, Zhang X, Zhang A. Higher serum trimethylamine-N-oxide levels are associated with increased abdominal aortic calcification in hemodialysis patients. Ren Fail. 2022;44:2019\u201327.","journal-title":"Ren Fail"},{"key":"1214_CR92","doi-asserted-by":"publisher","first-page":"BSR20200676","DOI":"10.1042\/BSR20200676","volume":"40","author":"F Guo","year":"2020","unstructured":"Guo F, Qiu X, Zhu Y, Tan Z, Li Z, Ouyang D. Association between plasma betaine levels and dysglycemia in patients with coronary artery disease. Biosci Rep. 2020;40:BSR20200676.","journal-title":"Biosci Rep"},{"key":"1214_CR93","first-page":"e947197","volume":"31","author":"HH Yang","year":"2025","unstructured":"Yang HH, Chen YC, Liu CH, Hsu BG. Serum Trimethylamine N-Oxide Levels as a Predictor of Peripheral Arterial Disease in Kidney Transplant Recipients. Med Sci Monit. 2025;31:e947197.","journal-title":"Med Sci Monit"},{"key":"1214_CR94","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1186\/s12872-024-04170-w","volume":"24","author":"S Meng","year":"2024","unstructured":"Meng S, Ni T, Du Q, Liu M, Ge P, Geng J, et al. Pre-procedural TMAO as a predictor for recurrence of atrial fibrillation after catheter ablation. BMC Cardiovasc Disord. 2024;24:750.","journal-title":"BMC Cardiovasc Disord"},{"key":"1214_CR95","doi-asserted-by":"publisher","first-page":"118597","DOI":"10.1016\/j.atherosclerosis.2024.118597","volume":"398","author":"A Aldujeli","year":"2024","unstructured":"Aldujeli A, Tsai TY, Haq A, Tatarunas V, Garg S, Hughes D, et al. The association between trimethylamine N-oxide levels and coronary microvascular dysfunction and prognosis in patients with ST-elevation myocardial infarction. Atherosclerosis. 2024;398:118597.","journal-title":"Atherosclerosis"},{"key":"1214_CR96","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/toxins15090572","volume":"15","author":"PY Huang","year":"2023","unstructured":"Huang PY, Hsu BG, Lai YH, Wang CH, Tsai JP. Serum Trimethylamine N-Oxide Level Is Positively Associated with Aortic Stiffness Measured by Carotid-Femoral Pulse Wave Velocity in Patients Undergoing Maintenance Hemodialysis. Toxins (Basel). 2023;15:572.","journal-title":"Toxins (Basel)"},{"key":"1214_CR97","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ajcnut.2022.12.013","volume":"117","author":"S Zhao","year":"2023","unstructured":"Zhao S, Tian Y, Wang S, Yang F, Xu J, Qin Z, et al. Prognostic value of gut microbiota-derived metabolites in patients with ST-segment elevation myocardial infarction. Am J Clin Nutr. 2023;117:499\u2013508.","journal-title":"Am J Clin Nutr"},{"key":"1214_CR98","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3390\/toxins14080526","volume":"14","author":"BG Hsu","year":"2022","unstructured":"Hsu BG, Wang CH, Lin YL, Lai YH, Tsai JP. Serum Trimethylamine N-Oxide Level Is Associated with Peripheral Arterial Stiffness in Advanced Non-Dialysis Chronic Kidney Disease Patients. Toxins (Basel). 2022;14:526.","journal-title":"Toxins (Basel)"},{"key":"1214_CR99","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1159\/000525972","volume":"147","author":"R Konieczny","year":"2022","unstructured":"Konieczny R, Zurawska-Plaksej E, Kaaz K, Czapor-Irzabek H, Bombala W, Mysiak A, et al. All-Cause Mortality and Trimethylamine N-Oxide Levels in Patients with Cardiovascular Disease. Cardiology. 2022;147:443\u201352.","journal-title":"Cardiology"},{"key":"1214_CR100","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1111\/ene.15249","volume":"30","author":"Z Li","year":"2023","unstructured":"Li Z, Hui J, Li S, Cao T, Zhang J, Mao X, et al. Trimethylamine N-oxide predicts stroke severity in diabetic patients with acute ischaemic stroke and is related to glycemic variability. Eur J Neurol. 2023;30:3478\u201386.","journal-title":"Eur J Neurol"},{"key":"1214_CR101","doi-asserted-by":"publisher","first-page":"577526","DOI":"10.1016\/j.jneuroim.2021.577526","volume":"354","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wang L, Cai J, Lei A, Liu C, Lin R, et al. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke. J Neuroimmunol. 2021;354:577526.","journal-title":"J Neuroimmunol"},{"key":"1214_CR102","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.21037\/apm-20-296","volume":"9","author":"Z Dong","year":"2020","unstructured":"Dong Z, Liang Z, Wang X, Liu W, Zhao L, Wang S, et al. The correlation between plasma trimethylamine N-oxide level and heart failure classification in northern Chinese patients. Ann Palliat Med. 2020;9:2862\u201371.","journal-title":"Ann Palliat Med"},{"key":"1214_CR103","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1212\/WNL.0000000000008862","volume":"94","author":"C Wu","year":"2020","unstructured":"Wu C, Xue F, Lian Y, Zhang J, Wu D, Xie N, et al. Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury. Neurology. 2020;94:e667\u201377.","journal-title":"Neurology"},{"key":"1214_CR104","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10571-019-00714-3","volume":"39","author":"Q Zhai","year":"2019","unstructured":"Zhai Q, Wang X, Chen C, Tang Y, Wang Y, Tian J, et al. Prognostic Value of Plasma Trimethylamine N-Oxide Levels in Patients with Acute Ischemic Stroke. Cell Mol Neurobiol. 2019;39:1201\u20136.","journal-title":"Cell Mol Neurobiol"},{"key":"1214_CR105","doi-asserted-by":"publisher","first-page":"BSR20190515","DOI":"10.1042\/BSR20190515","volume":"39","author":"M Rexidamu","year":"2019","unstructured":"Rexidamu M, Li H, Jin H, Huang J. Serum levels of Trimethylamine-N-oxide in patients with ischemic stroke. Biosci Rep. 2019;39:BSR20190515.","journal-title":"Biosci Rep"},{"key":"1214_CR106","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1038\/s41598-019-40638-y","volume":"9","author":"RH Chou","year":"2019","unstructured":"Chou RH, Chen CY, Chen IC, Huang HL, Lu YW, Kuo CS, et al. Trimethylamine N-Oxide, Circulating Endothelial Progenitor Cells, and Endothelial Function in Patients with Stable Angina. Sci Rep. 2019;9:4249.","journal-title":"Sci Rep"},{"key":"1214_CR107","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.amjcard.2018.12.018","volume":"123","author":"Z Sheng","year":"2019","unstructured":"Sheng Z, Tan Y, Liu C, Zhou P, Li J, Zhou J, et al. Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction. Am J Cardiol. 2019;123:894\u20138.","journal-title":"Am J Cardiol"},{"key":"1214_CR108","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12872-020-01669-w","volume":"20","author":"F Guo","year":"2020","unstructured":"Guo F, Qiu X, Tan Z, Li Z, Ouyang D. Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction. BMC Cardiovasc Disord. 2020;20:394.","journal-title":"BMC Cardiovasc Disord"},{"key":"1214_CR109","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41430-022-01104-7","volume":"77","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yao G. Significant correlation between the gut microbiota-derived metabolite trimethylamine-N-oxide and the risk of stroke: evidence based on 23 observational studies. Eur J Clin Nutr. 2023;77:731\u201340.","journal-title":"Eur J Clin Nutr"},{"key":"1214_CR110","doi-asserted-by":"publisher","first-page":"e37825","DOI":"10.1097\/MD.0000000000037825","volume":"103","author":"QA Khan","year":"2024","unstructured":"Khan QA, Asad M, Ali AH, Farrukh AM, Naseem U, Semakieh A, Carrion YL, Afzal M. Gut microbiota metabolites and risk of major adverse cardiovascular events and death: A systematic review and meta-analysis. Medicine. 2024;103:e37825.","journal-title":"Medicine"},{"key":"1214_CR111","doi-asserted-by":"publisher","first-page":"374","DOI":"10.5694\/mja2.50781","volume":"213","author":"W Li","year":"2020","unstructured":"Li W, Huang A, Zhu H, Liu X, Huang X, Huang Y, et al. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure. Med J Aust. 2020;213:374\u20139.","journal-title":"Med J Aust"},{"key":"1214_CR112","doi-asserted-by":"publisher","first-page":"2484018","DOI":"10.1155\/2022\/2484018","volume":"2022","author":"W Kong","year":"2022","unstructured":"Kong W, Ma J, Lin Y, Chen W. Positive Association of Plasma Trimethylamine-N-Oxide and Atherosclerosis in Patient with Acute Coronary Syndrome. Cardiovasc Ther. 2022;2022:2484018.","journal-title":"Cardiovasc Ther"},{"key":"1214_CR113","doi-asserted-by":"publisher","first-page":"14963","DOI":"10.1038\/s41598-021-93803-7","volume":"11","author":"V Senthong","year":"2021","unstructured":"Senthong V, Kiatchoosakun S, Wongvipaporn C, Phetcharaburanin J, Tatsanavivat P, Sritara P, et al. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand. Sci Rep. 2021;11:14963.","journal-title":"Sci Rep"},{"key":"1214_CR114","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3945\/ajcn.114.087692","volume":"100","author":"CA Miller","year":"2014","unstructured":"Miller CA, Corbin KD, da Costa KA, Zhang S, Zhao X, Galanko JA, et al. Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study. Am J Clin Nutr. 2014;100:778\u201386.","journal-title":"Am J Clin Nutr"},{"key":"1214_CR115","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijcard.2018.04.126","volume":"265","author":"X Liu","year":"2018","unstructured":"Liu X, Xie Z, Sun M, Wang X, Li J, Cui J, et al. Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomography. Int J Cardiol. 2018;265:18\u201323.","journal-title":"Int J Cardiol"},{"key":"1214_CR116","doi-asserted-by":"publisher","first-page":"231","DOI":"10.31083\/j.rcm.2021.01.299","volume":"22","author":"KB Waleed","year":"2021","unstructured":"Waleed KB, Tse G, Lu YK, Peng CN, Tu H, Ding LG, et al. Trimethylamine N-oxide is associated with coronary atherosclerotic burden in non-ST-segment myocardial infarction patients: SZ-NSTEMI prospective cohort study. Rev Cardiovasc Med. 2021;22:231\u20138.","journal-title":"Rev Cardiovasc Med"},{"key":"1214_CR117","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jacc.2025.08.047","volume":"87","author":"GA Mensah","year":"2025","unstructured":"Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology. J Am Coll Cardiol. 2025;87:1381\u2013404.","journal-title":"J Am Coll Cardiol"},{"key":"1214_CR118","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.jrn.2022.07.008","volume":"33","author":"M Mitrovic","year":"2023","unstructured":"Mitrovic M, Stankovic-Popovic V, Tolinacki M, Golic N, Sokovic BS, Veljovic K, et al. The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients-A Randomized Trial. J Ren Nutr. 2023;33:278\u201388.","journal-title":"J Ren Nutr"},{"key":"1214_CR119","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1038\/s41366-022-01213-0","volume":"46","author":"MRZ Ramos","year":"2022","unstructured":"Ramos MRZ, Felicidade I, de Oliveira CL, Wagner NRF, Mantovani MS, de Lima LVA, et al. Effect of probiotic supplementation on plasma metabolite profile after Roux-Y gastric bypass: a prospective, randomized, double-blind, placebo-controlled clinical trial. Int J Obes (Lond). 2022;46:2006\u201312.","journal-title":"Int J Obes (Lond)"},{"key":"1214_CR120","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.118.313565","volume":"123","author":"M Malik","year":"2018","unstructured":"Malik M, Suboc TM, Tyagi S, Salzman N, Wang J, Ying R, et al. Lactobacillus plantarum 299v Supplementation Improves Vascular Endothelial Function and Reduces Inflammatory Biomarkers in Men With Stable Coronary Artery Disease. Circ Res. 2018;123:1091\u2013102.","journal-title":"Circ Res"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-026-01214-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01214-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01214-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:02:47Z","timestamp":1790157767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12986-026-01214-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1214"],"URL":"https:\/\/doi.org\/10.1186\/s12986-026-01214-0","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RO has served on advisory board for Balchem Corporation. LM, BAW, GH, IE, JG, and RCC have no conflict of interest to declare.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"108"}}